Chemaitilly, Wassim

The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)

Bhakta, N., Liu, Q., Ness, K. K., Baassiri, M., Eissa, H., Yeo, F., Chemaitilly, W., Ehrhardt, M. J., Bass, J., Bishop, M. W., et al. (2017) · The Lancet

Childhood Cancer Survivors' Quality of LifeCancer survivorship and care

Cited by 862

Hypothalamic–Pituitary and Growth Disorders in Survivors of Childhood Cancer: An Endocrine Society* Clinical Practice Guideline

Sklar, C. A., Antal, Z., Chemaitilly, W., Cohen, L. E., Follin, C., Meacham, L. R., & Murad, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism

Childhood Cancer Survivors' Quality of LifeGrowth Hormone and Insulin-like Growth Factors

Cited by 224

Safety of growth hormone replacement in survivors of cancer and intracranial and pituitary tumours: a consensus statement

Boguszewski, M. C. S., Boguszewski, C. L., Chemaitilly, W., Cohen, L. E., Gebauer, J., Higham, C., Hoffman, A. R., Polak, M., Yuen, K. C. J., Alos, N., et al. (2022) · European Journal of Endocrinology

Growth Hormone and Insulin-like Growth FactorsPituitary Gland Disorders and Treatments

Cited by 117

Diagnosis of GH Deficiency as a Late Effect of Radiotherapy in Survivors of Childhood Cancers

Sfeir, J. G., Kittah, N. E. N., Tamhane, S. U., Jasim, S., Chemaitilly, W., Cohen, L. E., & Murad, M. H. (2018) · The Journal of Clinical Endocrinology & Metabolism

Growth Hormone and Insulin-like Growth FactorsPituitary Gland Disorders and Treatments

Cited by 35